INFANRIX is indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children aged 6 weeks through 6 years (prior to the seventh birthday).

Dec 10, 2024 · INFANRIX is a vaccine indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children aged 6 weeks through 6 years (prior to the …

May 29, 2024 · Infanrix (Diphtheria and Tetanus Toxoids and Acellular Pertussis) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug …

Infanrix® is a DTaP vaccine made by GlaxoSmithKline that was approved in 1997. It is an inactivated bacterial vaccine against diphtheria, tetanus, and pertussis (also known as “whooping cough”).

Infanrix hexa is a vaccine used to protect infants from six weeks of age and toddlers against diphtheria, tetanus, pertussis (whooping cough), hepatitis B, poliomyelitis (polio) and diseases such as bacterial …

Jul 1, 2025 · Find clinical guidance on Infanrix, including indications, dosing, safety, side effects and evidence-based insights for healthcare professionals.

INFANRIX is indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children aged 6 weeks through 6 years (prior to the seventh birthday).

Oct 27, 2023 · INFANRIX is indicated for active immunization against diphtheria, tetanus, and pertussis as a 5-dose series in infants and children aged 6 weeks through 6 years (prior to the seventh birthday).

INFANRIX prescription and dosage information for physicians and health care professionals. Pharmacology, adverse reactions, warnings, and INFANRIXside effects.

Aug 12, 2021 · INFANRIX hexa® may be administered to infants otherwise scheduled to receive concurrent INFANRIX® (diphtheria, tetanus and acellular pertussis vaccine) and Hepatitis B vaccine …